8.45
+0.27(+3.30%)
Currency In USD
| Previous Close | 8.18 |
| Open | 8.42 |
| Day High | 8.53 |
| Day Low | 8.15 |
| 52-Week High | 14.13 |
| 52-Week Low | 3.78 |
| Volume | 142,758 |
| Average Volume | 516,766 |
| Market Cap | 156.24M |
| PE | -7.68 |
| EPS | -1.1 |
| Moving Average 50 Days | 6.97 |
| Moving Average 200 Days | 6.94 |
| Change | 0.27 |
If you invested $1000 in OptimizeRx Corporation (OPRX) 10 years ago, it would be worth $2,327.82 as of April 20, 2025 at a share price of $8.45. Whereas If you bought $1000 worth of OptimizeRx Corporation (OPRX) shares 5 years ago, it would be worth $891.35 as of April 20, 2025 at a share price of $8.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
GlobeNewswire Inc.
Mar 11, 2025 11:30 AM GMT
No Stockholder Action Required at this TimeWALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage he
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
GlobeNewswire Inc.
Mar 10, 2025 11:30 AM GMT
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading teamWALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
GlobeNewswire Inc.
Feb 27, 2025 12:30 PM GMT
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, w
Data not available